Your browser doesn't support javascript.
loading
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.
van Leeuwen, Leanne P M; GeurtsvanKessel, Corine H; Ellerbroek, Pauline M; de Bree, Godelieve J; Potjewijd, Judith; Rutgers, Abraham; Jolink, Hetty; van de Veerdonk, Frank; van Gorp, Eric C M; de Wilt, Faye; Bogers, Susanne; Gommers, Lennert; Geers, Daryl; Bruns, Anke H W; Leavis, Helen L; van Haga, Jelle W; Lemkes, Bregtje A; van der Veen, Annelou; de Kruijf-Bazen, S F J; van Paassen, Pieter; de Leeuw, Karina; van de Ven, Annick A J M; Verbeek-Menken, Petra H; van Wengen, Annelies; Arend, Sandra M; Ruten-Budde, Anja J; van der Ent, Marianne W; van Hagen, P Martin; Sanders, Rogier W; Grobben, Marloes; van der Straten, Karlijn; Burger, Judith A; Poniman, Meliawati; Nierkens, Stefan; van Gils, Marit J; de Vries, Rory D; Dalm, Virgil A S H.
Afiliação
  • van Leeuwen LPM; Department of Viroscience, Erasmus MC University Medical Center, Rotterdam, The Netherlands; Travel Clinic, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • GeurtsvanKessel CH; Department of Viroscience, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Ellerbroek PM; Department of Internal Medicine, UMC Utrecht, Utrecht, The Netherlands.
  • de Bree GJ; Department of Infectious Diseases, Amsterdam UMC, Amsterdam, The Netherlands.
  • Potjewijd J; Department of Internal Medicine, Division of Nephrology and Clinical Immunology, Maastricht UMC, Maastricht, The Netherlands.
  • Rutgers A; Department of Rheumatology and Clinical Immunology, UMC Groningen, Groningen, The Netherlands.
  • Jolink H; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • van de Veerdonk F; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Gorp ECM; Department of Viroscience, Erasmus MC University Medical Center, Rotterdam, The Netherlands; Travel Clinic, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • de Wilt F; Department of Viroscience, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Bogers S; Department of Viroscience, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Gommers L; Department of Viroscience, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Geers D; Department of Viroscience, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Bruns AHW; Department of Internal Medicine, UMC Utrecht, Utrecht, The Netherlands.
  • Leavis HL; Department of Internal Medicine, UMC Utrecht, Utrecht, The Netherlands.
  • van Haga JW; Department of Infectious Diseases, Amsterdam UMC, Amsterdam, The Netherlands.
  • Lemkes BA; Department of Infectious Diseases, Amsterdam UMC, Amsterdam, The Netherlands.
  • van der Veen A; Department of Infectious Diseases, Amsterdam UMC, Amsterdam, The Netherlands.
  • de Kruijf-Bazen SFJ; Department of Internal Medicine, Division of Nephrology and Clinical Immunology, Maastricht UMC, Maastricht, The Netherlands.
  • van Paassen P; Department of Internal Medicine, Division of Nephrology and Clinical Immunology, Maastricht UMC, Maastricht, The Netherlands.
  • de Leeuw K; Department of Rheumatology and Clinical Immunology, UMC Groningen, Groningen, The Netherlands.
  • van de Ven AAJM; Department of Rheumatology and Clinical Immunology, UMC Groningen, Groningen, The Netherlands.
  • Verbeek-Menken PH; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • van Wengen A; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Arend SM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Ruten-Budde AJ; Department of Biostatistics, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van der Ent MW; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van Hagen PM; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Sanders RW; Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Grobben M; Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van der Straten K; Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Burger JA; Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Poniman M; Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Nierkens S; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • van Gils MJ; Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • de Vries RD; Department of Viroscience, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Dalm VASH; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: v.dalm@erasmusmc.nl.
J Allergy Clin Immunol ; 149(6): 1949-1957, 2022 06.
Article em En | MEDLINE | ID: mdl-35421449

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 / Vacina de mRNA-1273 contra 2019-nCoV / Doenças Genéticas Inatas / Síndromes de Imunodeficiência Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 / Vacina de mRNA-1273 contra 2019-nCoV / Doenças Genéticas Inatas / Síndromes de Imunodeficiência Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda